388
Views
3
CrossRef citations to date
0
Altmetric
Articles

Tumor apelin immunoreactivity is correlated with body mass index in ovarian high grade serous carcinoma

ORCID Icon, , , , , , , & ORCID Icon show all

References

  • Altinkaya SO, Nergiz S, Küçük M, Yüksel H. 2015. Apelin levels are higher in obese patients with endometrial cancer. J Obstet Gynaecol Res. 41:294–300. doi:10.1111/jog.12503.
  • Berta J, Hoda MA, Laszlo V, Rozsas A, Garay T, Torok S, Grusch M, Berger W, Paku S, Renyi-Vamos F, Masri B, Tovari J, Groger M, Klepetko W, Hegedus B, Dome B. 2014. Apelin promotes lymphangiogenesis and lymph node metastasis. Oncotarget. 5:4426–4437. doi:10.18632/oncotarget.2032.
  • Booth A, Magnuson A, Fouts J, Foster M. 2015. Adipose tissue, obesity and adipokines: role in cancer promotion. Horm Mol Biol Clin Invest. 21:57–74. doi:10.1515/hmbci-2014-0037.
  • Chen Y, Zhang L, Liu W, Liu X. 2015. Prognostic significance of the tumor-stroma ratio in epithelial ovarian cancer. Biomed Res Int. 2015:589301–589309. doi:10.1155/2015/589301.
  • Christofori G. 2003. Changing neighbours, changing behaviour: cell adhesion molecule‐mediated signalling during tumour progression. EMBO J. 22:2318–2323. doi:10.1093/emboj/cdg228.
  • de Kruijf EM, van Nes JG, van de Velde CJ, Putter H, Smit VT, Liefers GJ, Kuppen PJ, Tollenaar RA, Mesker WE. 2011. Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Res Treat. 125:687–696. doi:10.1007/s10549-010-0855-6.
  • Eyries M, Siegfried G, Ciumas M, Montagne K, Agrapart M, Lebrin F, Soubrier F. 2008. Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res. 103:432–440. doi:10.1161/CIRCRESAHA.108.179333.
  • Fazeli MS, Dashti H, Akbarzadeh S, Assadi M, Aminian A, Keramati MR, Nabipour I. 2013. Circulating levels of novel adipocytokines in patients with colorectal cancer. Cytokine. 62:81–85. doi:10.1016/j.cyto.2013.02.012.
  • Feng M, Yao G, Yu H, Qing Y, Wang K. 2016. Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancer. BMC Cancer. 16:794–801. doi:10.1186/s12885-016-2815-y.
  • Inan S, Oztukcan S, Vatansever S, Ermertcan AT, Zeybek D, Oksal A, Giray G, Muftuoglu S. 2006. Histopathological and ultrastructural effects of glycolic acid on rat skin. Acta Histochem. 108:37–47. doi:10.1016/j.acthis.2006.01.007.
  • Jones DH, Nestore M, Henophy S, Cousin J, Comtois AS. 2014. Increased cardiovascular risk factors in breast cancer survivors identified by routine measurements of body composition, resting heart rate and arterial blood pressure. SpringerPlus. 3:150–156. doi:10.1186/2193-1801-3-150.
  • Kälin RE, Kretz MP, Meyer AM, Kispert A, Heppner FL, Brändli AW. 2007. Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis. Dev Biol. 305:599–614. doi:10.1016/j.ydbio.2007.03.004.
  • Köbel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, Prentice LM, Miller D, Santos J, Swenerton K, Gilks CB, Huntsman D. 2008. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med. 5(e232):1749–1760. doi:10.1371/journal.pmed.0050232.
  • Koda M, Sulkowska M, Kanczuga-Koda L, Surmacz E, Sulkowski S. 2007. Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol. 60:902–906. doi:10.1136/jcp.2006.041004.
  • Kotsopoulos IC, Papanikolaou A, Lambropoulos AF, Papazisis KT, Tsolakidis D, Touplikioti P, Tarlatzis BC. 2014. Serous ovarian cancer signaling pathways. Int J Gynecol Cancer. 24:410–417. doi:10.1097/IGC.0000000000000079.
  • Leeper NJ, Tedesco MM, Kojima Y, Schultz GM, Kundu RK, Ashley EA, Tsao PS, Dalman RL, Quertermous T. 2009. Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. Am J Physiol Heart Circ Physiol. 296:H1329–H1335. doi:10.1152/ajpheart.01341.2008.
  • Mazières J, Brugger W, Cappuzzo F, Middel P, Frosch A, Bara I, Klingelschmitt G, Klughammer B. 2013. Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: re-analysis of the SATURN study. Lung Cancer. 82:231–237. doi:10.1016/j.lungcan.2013.07.016.
  • Peng X, Li F, Wang P, Jia S, Sun L, Huo H. 2015. Apelin-13 induces MCF-7 cell proliferation and invasion via phosphorylation of ERK1/2. Int J Mol Med. 36:733–738. doi:10.3892/ijmm.2015.2265.
  • Petushi S, Garcia FU, Haber MM, Katsinis C, Tozeren A. 2006. Large-scale computations on histology images reveal grade-differentiating parameters for breast cancer. BMC Med Imag. 6:14–25. doi:10.1186/1471-2342-6-14.
  • Sundstrom A, Grabocka E, Bar-Sagi D, Mishra B. 2016. Histological image processing features induce a quantitative characterization of chronic tumor hypoxia. PLoS One. 11:e0153623. doi:10.1371/journal.pone.0153623.
  • Tingulstad S, Skjeldestad FE, Halvorsen TB, Hagen B. 2003. Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol. 101:885–891.
  • Wang XY, Garibaldi J, Ozen T 2003 Application of the fuzzy C-means clustering method on the analysis of non pre-processed FTIR data for cancer diagnosis. Int. Conf. Austral N Z Intell Inform Sys (ANZIIS), Sydney, Australia, pp. 233–238. is http://www.aprs.org.au/anziis2003/Attach/ANZIIS%20CD%20Proceedings.pdf.
  • Wang Z, Cai J, Zhang M, Wang X, Chi H, Feng H, Yang X. 2016. Positive expression of human cytomegalovirus phosphoprotein 65 in atherosclerosis. Biomed Res Int. 2016(4067685):7. doi:10.1155/2016/4067685.
  • Yi Y, Tsai SH, Cheng JC, Wang EY, Anglesio MS, Cochrane DR, Fuller M, Gibb EA, Wei W, Huntsman DG, Karsan A, Hoodless PA. 2017. APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner. Gynecol Oncol. 147:663–671. doi:10.1016/j.ygyno.2017.10.016.
  • Zhang GY, Ahmed N, Riley C, Oliva K, Barker G, Quinn MA, Rice GE. 2005. Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma. Br J Cancer. 92:113–119. doi:10.1038/sj.bjc.6602244.
  • Zuurbier L, Rahman A, Cordes M, Scheick J, Wong TJ, Rustenburg F, Joseph JC, Dynoodt P, Casey R, Drillenburg P, Gerhards M, Barat A, Klinger R, Fender B, O’Connor DP, Betge J, Ebert MP, Gaiser T, Prehn JHM, Griffioen AW, van Grieken NCT, Ylstra B, Byrne AT, van der Flier LG, Gallagher WM, Postel R. 2017. Apelin: a putative novel predictive biomarker for bevacizumab response in colorectal cancer. Oncotarget. 8:42949–42961. doi:10.18632/oncotarget.17306.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.